<?xml version="1.0" encoding="UTF-8"?>
<framework>
	<description>ETAPES (temporary)</description>
	<question>
		<title>1. Is the DHT a telemonitoring device?</title>
		<option>
			<value>Yes</value>
			<question>
				<title>2. Does the DHT relate to one of the five pathologies?*</title>
				<description>*  - Heart failure  - Renal failure  - Respiratory failure  - Diabetes  - Implantable cardiac prostheses</description>
				<option>
					<value>Yes</value>
					<condition>Eligible for ETAPES</condition>
					<outcome>ETAPES</outcome>
					<outcome>LPPR</outcome>
					<description>Traditional pathway through HAS (LPPR) sustainable reimbursement</description>
					<question>
						<title>3. Does the DHT have a CE-marking?</title>
						<option>
							<value>Yes</value>
							<question>
								<title>4. Is the DHT meant for individual use?</title>
								<option>
									<value>Yes</value>
									<question>
										<title>5. Does the DHT have a telecommunication function?</title>
										<option>
											<value>Yes</value>
											<condition>Application for inclusion LPPR</condition>
											<evidence>Evidence required</evidence>
											<question>
												<title>6. Does the DHT have a positive impact for the patient and the public health?</title>
												<option>
													<value>Yes</value>
													<condition>Sufficient actual clinical benefit</condition>
													<condition>Opinion favourable for inclusion LPPR</condition>
													<condition>CAV evaluation I till V</condition>
													<outcome>Ministry rejects or accepts DHT for inclusion</outcome>
												</option>
												<option>
													<value>No</value>
													<condition>Insufficient actual clinical benefit</condition>
													<outcome>Opinion unfavourable for inclusion LPPR</outcome>
												</option>
											</question>
										</option>
										<option>
											<value>No</value>
											<outcome>Not able to apply for inclusion LPPR</outcome>
											<outcome>Article 51 of the LFSS 2018</outcome>
										</option>
									</question>
								</option>
								<option>
									<value>No</value>
									<outcome>Not able to apply for inclusion LPPR</outcome>
									<outcome>Article 51 of the LFSS 2018</outcome>
								</option>
							</question>
						</option>
						<option>
							<value>No</value>
							<outcome>Not able to apply for inclusion LPPR</outcome>
							<outcome>Article 51 of the LFSS 2018</outcome>
						</option>
					</question>
				</option>
				<option>
					<value>No</value>
					<outcome>Not eligable for ETAPES</outcome>
					<description>Traditional pathway through HAS (LPPR) sustainable reimbursement</description>
					<question>
						<title>3. Does the DHT have a CE-marking?</title>
						<option>
							<value>Yes</value>
							<question>
								<title>4. Is the DHT meant for individual use?</title>
								<option>
									<value>Yes</value>
									<question>
										<title>5. Does the DHT have a telecommunication function?</title>
										<option>
											<value>Yes</value>
											<condition>Application for inclusion LPPR</condition>
											<evidence>Evidence required</evidence>
											<question>
												<title>6. Does the DHT have a positive impact for the patient and the public health?</title>
												<option>
													<value>Yes</value>
													<condition>Sufficient actual clinical benefit</condition>
													<condition>Opinion favourable for inclusion LPPR</condition>
													<condition>CAV evaluation I till V</condition>
													<outcome>Ministry rejects or accepts DHT for inclusion</outcome>
												</option>
												<option>
													<value>No</value>
													<condition>Insufficient actual clinical benefit</condition>
													<outcome>Opinion unfavourable for inclusion LPPR</outcome>
												</option>
											</question>
										</option>
										<option>
											<value>No</value>
											<outcome>Not able to apply for inclusion LPPR</outcome>
											<outcome>Article 51 of the LFSS 2018</outcome>
										</option>
									</question>
								</option>
								<option>
									<value>No</value>
									<outcome>Not able to apply for inclusion LPPR</outcome>
									<outcome>Article 51 of the LFSS 2018</outcome>
								</option>
							</question>
						</option>
						<option>
							<value>No</value>
							<outcome>Not able to apply for inclusion LPPR</outcome>
							<outcome>Article 51 of the LFSS 2018</outcome>
						</option>
					</question>
				</option>
			</question>
		</option>
		<option>
			<value>No</value>
			<outcome>Not eligable for ETAPES</outcome>
			<description>Traditional pathway through HAS (LPPR) sustainable reimbursement</description>
			<question>
				<title>3. Does the DHT have a CE-marking?</title>
				<option>
					<value>Yes</value>
					<question>
						<title>4. Is the DHT meant for individual use?</title>
						<option>
							<value>Yes</value>
							<question>
								<title>5. Does the DHT have a telecommunication function?</title>
								<option>
									<value>Yes</value>
									<condition>Application for inclusion LPPR</condition>
									<evidence>Evidence required</evidence>
									<question>
										<title>6. Does the DHT have a positive impact for the patient and the public health?</title>
										<option>
											<value>Yes</value>
											<condition>Sufficient actual clinical benefit</condition>
											<condition>Opinion favourable for inclusion LPPR</condition>
											<condition>CAV evaluation I till V</condition>
											<outcome>Ministry rejects or accepts DHT for inclusion</outcome>
										</option>
										<option>
											<value>No</value>
											<condition>Insufficient actual clinical benefit</condition>
											<outcome>Opinion unfavourable for inclusion LPPR</outcome>
										</option>
									</question>
								</option>
								<option>
									<value>No</value>
									<outcome>Not able to apply for inclusion LPPR</outcome>
									<outcome>Article 51 of the LFSS 2018</outcome>
								</option>
							</question>
						</option>
						<option>
							<value>No</value>
							<outcome>Not able to apply for inclusion LPPR</outcome>
							<outcome>Article 51 of the LFSS 2018</outcome>
						</option>
					</question>
				</option>
				<option>
					<value>No</value>
					<outcome>Not able to apply for inclusion LPPR</outcome>
					<outcome>Article 51 of the LFSS 2018</outcome>
				</option>
			</question>
		</option>
	</question>
</framework>